Key result
Renal dysfunction was significantly associated with cardiovascular mortality in patients with ischemic and nonischemic dilated cardiomyopathy (P<0.001).
Why the study?
Does renal dysfunction predict cardiovascular mortality in patients with ischemic and nonischemic dilated cardiomyopathy?
Observational (n=637)
Does renal dysfunction predict cardiovascular mortality in patients with ischemic and nonischemic dilated cardiomyopathy?
p-value: p=<0.001
Renal dysfunction is a significant prognostic marker for cardiovascular mortality in patients admitted with decompensated ischemic or nonischemic dilated cardiomyopathy.
Renal dysfunction may aid prognostication in dilated cardiomyopathy; hypothesis-generating and requires prospective validation.
BACKGROUND: Chronic heart failure (CHF) is a major and growing public health problem resulting from the cardiac damage caused by a variety of disease processes. CHF has many comorbid conditions such as hypertension, coronary artery disease, peripheral artery disease and chronic kidney disease (CKD). Some of the chronic conditions may have an effect on cardiac mortality in CHF patients. We have investigated the effect of renal dysfunction on cardiovascular mortality in patients with ischemic dilated cardiomyopathy (DCM) and nonischemic DCM. METHODS: Six hundred and thirty-seven patients with DCM were evaluated between January 2003 and January 2011. All individuals in the study population were admitted to the cardiology clinic because of decompensated heart failure. In this prospective observational study, a total of 637 patients [409 men, 228 women, 18-94 years old, mean age 63 ± 13 years; New York Heart Association (NYHA) functional class II-IV] with diagnoses of ischemic (402) and nonischemic (235) DCM were enrolled in the study. Baseline glomerular filtration rate was calculated using the Cockcroft-Gault equation. RESULTS: By the end of the study, 228 patients had died due to cardiovascular reasons. Both DCM types had similar cardiovascular mortality [151 patients with ischemic DCM (37%) vs. 77 patients with nonischemic DCM (32%); P = NS]. Renal dysfunction had an effect on cardiovascular mortality in patients with ischemic and nonischemic DCM (respectively, glomerular filtration rate 54 ± 24, 56 ± 24; P < 0.001). CONCLUSION: We have demonstrated that renal function is a prognostic risk marker in patients with ischemic and nonischemic DCM.
No takes yet. Share an insight, caveat, or question.
Ertaş et al. (2012) conducted an observational in Dilated cardiomyopathy with decompensated heart failure (n=637). Renal dysfunction was evaluated on Cardiovascular mortality (p=<0.001). Renal dysfunction was significantly associated with cardiovascular mortality in patients with ischemic and nonischemic dilated cardiomyopathy (P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: